Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat

Author： Jaskiw George   Bongiovanni Rodolfo  

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.172, Iss.1, 2004-02, pp. : 100-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain

By Kaur S.   Ozer H.   Starr M.  

European Journal of Pharmacology, Vol. 332, Iss. 2, 1997-08 ,pp. : 153-160

Elsevier

Access to resources Recommend Favorite

Haloperidol-induced catalepsy is absent in dopamine D 2 , but maintained in dopamine D 3 receptor knock-out mice

By Boulay D.   Depoortere R.   Oblin A.   Sanger D.J.   Schoemaker H.   Perrault G.  

European Journal of Pharmacology, Vol. 391, Iss. 1, 2000-03 ,pp. : 63-73

Elsevier

Access to resources Recommend Favorite

Arginine-aspartate and haloperidol-induced neurobehavioral effects in the rat

By Patacchioli F.R.   Di Grezia R.   Angelucci L.  

European Journal of Pharmacology, Vol. 299, Iss. 1, 1996-03 ,pp. : 29-32

Elsevier

Access to resources Recommend Favorite

Aripiprazole beats haloperidol-induced hyperprolactinaemia

By  

Reactions Weekly, Vol. 1, Iss. 1175, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

SR46349-B, a 5-HT 2A/2C Receptor Antagonist, Potentiates Haloperidol-induced Dopamine Release in Rat Medial Prefrontal Cortex and Nucleus Accumbens

By Bonaccorso S.   Meltzer H.Y.   Li Z.   Dai J.   Alboszta A.R.   Ichikawa J.  

Neuropsychopharmacology, Vol. 27, Iss. 3, 2002-09 ,pp. : 430-441

Elsevier

Access to resources Recommend Favorite